Biocryst Pharmaceuticals (BCRX) FCF Margin Growth (1y) (2011 - 2026)
Biocryst Pharmaceuticals (BCRX) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.10 Bn | 214.41 Mn | 2,263.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,263.00 |
| Mar 31, 2026 | -2,099.00 |
| Dec 31, 2025 | 4.14 Mn |
| Sep 30, 2025 | 1,908.00 |
| Jun 30, 2025 | 2,567.00 |
| Mar 31, 2025 | 3,922.00 |
| Dec 31, 2024 | 420.00 |
| Sep 30, 2024 | 3,073.00 |
| Jun 30, 2024 | 2,234.00 |
| Mar 31, 2024 | 1,119.00 |
| Dec 31, 2023 | 2,282.00 |
| Sep 30, 2023 | 1,894.00 |
| Jun 30, 2023 | 1,936.00 |
| Mar 31, 2023 | 8,734.00 |
| Dec 31, 2022 | 4,054.00 |
| Sep 30, 2022 | 1,465.00 |
| Jun 30, 2022 | 976.00 |
| Mar 31, 2022 | 16,398.00 |
| Dec 31, 2021 | 99,172.00 |
| Sep 30, 2021 | 57,207.00 |